NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 84 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $6,000 | -60.0% | 3,032 | 0.0% | 0.00% | – |
| Q4 2021 | $15,000 | -80.8% | 3,032 | -72.0% | 0.00% | – |
| Q3 2021 | $78,000 | +100.0% | 10,811 | +158.6% | 0.00% | – |
| Q2 2021 | $39,000 | -35.0% | 4,181 | -14.1% | 0.00% | – |
| Q1 2021 | $60,000 | -15.5% | 4,870 | -4.0% | 0.00% | – |
| Q4 2020 | $71,000 | +16.4% | 5,072 | 0.0% | 0.00% | – |
| Q3 2020 | $61,000 | -39.0% | 5,072 | -16.2% | 0.00% | – |
| Q2 2020 | $100,000 | – | 6,051 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,225,000 | $15,080,000 | 2.22% |
| EcoR1 Capital, LLC | 3,122,704 | $38,440,000 | 1.70% |
| Redmile Group, LLC | 4,117,569 | $50,687,000 | 0.71% |
| HighVista Strategies LLC | 71,235 | $877,000 | 0.65% |
| Boxer Capital, LLC | 1,501,058 | $18,478,000 | 0.63% |
| Baker Brothers Advisors | 3,821,740 | $47,046,000 | 0.20% |
| Sio Capital Management, LLC | 38,312 | $472,000 | 0.10% |
| Highland Private Wealth Management | 46,999 | $579,000 | 0.10% |
| Point72 Asset Management, L.P. | 1,308,600 | $16,109,000 | 0.08% |
| Granahan Investment Management | 200,518 | $2,468,000 | 0.05% |